title: [Catheter-Based Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up 1996-2016].
abstract: Since the first publication in 1995 percutaneous septal ablation (acronyms in alphabetical order: ASA, ESA, NSMR, PTSMA, TASH, among others) has made its way from a small case series into the international guidelines for patients with HOCM and symptoms not responding to medical treatment. We now report on the long-term course (20 years) in the first 6 cases who were successfully treated in our institution in early 1996, published in this Journal shortly thereafter.
authors.affiliation: Klinik für Kardiologie, Herz- und Diabeteszentrum NRW, Klinik der Ruhr-Universität Bochum, Bad Oeynhausen.
authors.forename: Lothar
authors.initials: L
authors.lastname: Faber
authors.affiliation: Klinik für Kardiologie, Herz- und Diabeteszentrum NRW, Klinik der Ruhr-Universität Bochum, Bad Oeynhausen.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Gleichmann
authors.affiliation: Klinik für Kardiologie, Herz- und Diabeteszentrum NRW, Klinik der Ruhr-Universität Bochum, Bad Oeynhausen.
authors.forename: Dieter
authors.initials: D
authors.lastname: Horstkotte
authors.affiliation: Medizinische Klinik, Leopoldina-Krankenhaus Schweinfurt.
authors.forename: Hubert
authors.initials: H
authors.lastname: Seggewiss
mesh_terms: D000328:Adult; D000368:Aged; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis* / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006346:Heart Septum / Q000601:surgery*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome